Skip to main content

$0.260 0.035 (15.56%)

High

$0.26

Low

$0.22

Trades

21

Turnover

$59,559

Volume

239,872
30 June 2023 at 4:10pm
Register to track UBI and receive email alerts.

Tn Antigen Peter Mac Development Clinical Study Results

StockBot

416,823 posts

UBI released this announcement to the ASX on 19 April 2022, 9:48. The announcement is marked as price sensitive, and is 4 page(s) in length and 258.85kb in size.

You can view all announcements from UBI and see how they appear on a price chart on the announcements page.

At the date of this announcement, UBI was 0.008% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 542nd most shorted stock on the ASX with 0.030% of total shares short sold as of the latest reported data (05 October 2023).

Other Recent Announcements from UBI
Results of 2023 Annual General meeting 22 May 2023, 12:14
CEO's AGM address to Securityholders 22 May 2023, 8:33
Q1 2023 Results 11 May 2023, 15:41
Tn Antigen Peter Mac Development Clinical Study Results 19 April 2022, 9:48
Trading Halt 19 April 2022, 9:15
Form 604 - JM Financial Group Ltd 18 March 2022, 10:44
Clarification Announcement 10 March 2022, 15:57
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track UBI and receive email alerts.